A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
A Jack Russell Terrier from California has entered the record books after setting the fastest time to pop 100 balloons by a dog.
A woman who wants to use her dead daughter's frozen eggs to give birth to her own grandchild, has won a Court of Appeal battle.
June closes on a disappointing note